Deletion of the 5′ ABL region in Philadelphia chromosome positive chronic myeloid leukemia: Frequency, origin and prognosis

Leukemia and Lymphoma

Volumn 44, Issue 8, 2003, Pages 1333-1338

  Morel, Frédéric ^a,b   Ka, Chandran ^a,b   Le Bris, Marie Josée ^b   Herry, Angèle ^a,b   Morice, Patrick ^c   Bourquard, Pascal ^c   Abgrall, Jean François ^b   Berthou, Christian ^b   De Braekeleer, Marc ^a,b  

^a FACULTÉ DE MÉDECINE ET DES SCIENCES DE LA SANTÉ   (France)

^b CHU MORVAN   (France)

^c Service d'Hematologie   (France)

Author keywords

5 abl deletion; Chronic myeloid leukemia; Fluorescence in situ hybridization; Philadelphia chromosome; Prognosis; Survival

Indexed keywords

ALPHA INTERFERON; BCR ABL PROTEIN; BUSULFAN; CYTOSTATIC AGENT; HYDROXYUREA; PROTEIN TYROSINE KINASE;

ADULT; ARTICLE; CANCER SURVIVAL; CHROMOSOME 9; CHROMOSOME DELETION; CHROMOSOME TRANSLOCATION; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOGENETICS; DISEASE COURSE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLOW UP; FUSION GENE; HUMAN; MALE; METAPHASE; NUCLEIC ACID PROBE; ONCOGENE; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL; PROGNOSIS; PROMOTER REGION; ADOLESCENT; BONE MARROW; CHI SQUARE DISTRIBUTION; DNA PROBE; GENE DELETION; GENETICS; MIDDLE AGED; MORTALITY; MYELOID LEUKEMIA; PATHOLOGY; TREATMENT OUTCOME;

ADOLESCENT; ADULT; BONE MARROW; CHI-SQUARE DISTRIBUTION; DNA PROBES; FEMALE; FOLLOW-UP STUDIES; GENES, ABL; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LEUKEMIA, MYELOID, CHRONIC; LEUKEMIA, MYELOID, PHILADELPHIA-POSITIVE; MALE; METAPHASE; MIDDLE AGED; PHILADELPHIA CHROMOSOME; PROGNOSIS; SEQUENCE DELETION; TREATMENT OUTCOME;

EID: 0038466278     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/1042819031000097384     Document Type: Article

References (24)

1. Melo, J.V. (1996) "The molecular biology of chronic myeloid leukemia", Leukemia 10, 751-756.
2. Thijsen, S., Schuurhui, G., van Oostveen, J. and Ossenkoppele, G. (1999) "Chronic myeloid leukemia from basics to bedside", Leukemia 13, 1646-1647.
3. Melo, J.V, Hochhaus, A., Yan, X.H. and Goldman, J.M. (1996) "Lack of correlation between ABL-BCR expression and response to interferon-alpha in chronic myeloid leukemia", British Journal of Haematology 92, 684-686.
4. Sokal, J.E., Cox, E.B., Baccarani, M., Tura, S., Gomez, G.A., Robertson, J.E., Tso, C.Y., Braun, T.J., Clarkson, B.D. and Cervantes, F. (1984) "Prognostic discrimination in 'good-risk' chronic granulocytic leukemia", Blood 63, 789-799.
5. Hasford, J., Pfirrmann, M., Hehlmann, R., Allan, N.C., Baccarani, M., Kluin-Nelemans, J.C., Alimena, G., Steegman, J.L. and Ansari, H. (1998) "A new prognostic score of survival of patients with chronic myeloid leukemia treated with interferon alfa. Writing Committee for the Collaborative CML Prognostic Factors Project Group", Journal of the National Cancer Institute 90, 580-588.
6. Huntly, B.J.P., Reid, A.G., Bench, A.J., Campbell, L.J., Telford, N., Shepherd, P., Szer, J., Prince, H.M., Turner, P., Grace, C., Nacheva, E.P. and Green, A.R. (2001) "Deletions of the derivative chromosome 9 occur at the time of the Philadelphia translocation and provide a powerful and independent prognostic indicator in chronic myeloid leukemia", Blood 98, 1732-1738.
7. Sinclair, P.B., Nacheva, E.P., Leversha, M., Telford, N., Chang, J., Reid, A., Bench, A., Champion, K., Huntly, B. and Green, A.R. (2000) "Large deletions at the t(9;22) breakpoint are common and may identify a poor-prognosis subgroup of patients with chronic myeloid leukemia", Blood 95, 738-744.
8. Dewald, G.W., Wyatt, W.A. and Silver, R.T. (1999) "Atypical BCR and ABL D-FISH patterns in chronic myeloid leukemia and their possible role in therapy", Leukemia and Lymphoma 34, 481-491.
9. Grand, F., Kulkarni, S., Chase, A., Goldman, J.M., Gordon, M. and Cross, N.C.P. (1999) "Frequent deletion of hSNF5/INI1, a component of the SWI/SNF complex, in chronic myeloid leukemia", Cancer Research 59, 3870-3874.
10. Le Gouill, S., Talmant, P., Milpied, N., Daviet, A., Ancelot, M., Moreau, P., Harousseau, J.L., Bataille, R. and Avet-Loiseau, H. (2000) "Fluorescence in situ hybridization on peripheral-blood specimens is a reliable method to evaluate cytogenetic response in chronic myeloid leukemia", Journal of Clinical Oncology 18, 1533-1538.
11. Herens, C., Tassin, F., Lemaire, V., Beguin, Y., Collard, E., Lampertz, S., Croisiau, C., Lecomte, M., De Prijk, B., Longrée, L. and Koulischer, L. (2000) "Deletion of the 5′-ABL region: a recurrent anomaly detected by fluorescence in situ hybridization in about 10% of Philadelphia-positive chronic myeloid leukemia patients", British Journal of Haematology 110, 214-216.
12. Markovic, V.D., Bouman, D., Bayani, J., Al-Maghrabi, J., Kamel-Reid, S. and Squire, J.A. (2000) "Lack of BCR/ABL reciprocal fusion in variant Philadelphia chromosome translocations: a use of double fusion signal FISH and spectral karyotyping", Leukemia 14, 1160.
13. Kolomietz, E., Al-Maghrabi, J., Brennan, S., Karaskova, J., Minkin, S., Lipton, J. and Squire, J.A. (2001) "Primary chromosomal rearrangements of leukemia are frequently accompanied by extensive submicroscopic deletions and may lead to altered prognosis", Blood 97, 3581-3588.
14. Mohr, B., Bornhauser, M., Platzbecker, U., Freiberg-Richter, J., Naumann, R., Prange-Krex, G., Mohm, J., Kroschinsky, F., Ehninger, G. and Thiede, C. (2001) "Problems with interphase fluorescence in situ hybridization in detecting BCR/ABL-positive cells in some patients using a novel technique with extra signals", Cancer Genetics and Cytogenetics 127, 111-117.
15. Cohen, N., Rozenfeld-Granot, G., Hardan, I., Brok-Simoni, F., Amariglio, N., Rechavi, G. and Trakhtenbrot, L. (2001) "Subgroup of patients with Philadelphia-positive chronic myelogenous leukemia characterized by a deletion of 9q proximal to ABL gene: expression profiling, resistance to interferon therapy, and poor prognosis", Cancer Genetics and Cytogenetics 128, 114-119.
16. Gonzalez, F.A., Anguita, E., Mora, A., Asenjo, S., Lopez, I., Polo, M. and Villegas, A. (2001) "Deletion of BCR region 3′ in chronic myelogenous leukemia", Cancer Genetics and Cytogenetics 130, 68-74.
17. Calabrese, G., Stuppia, L., Guanciali Franchi, P., Peila, R., Morizio, E., Liberati, A.M., Spadano, A., Di Lorenzo, R., Donti, E., Antonucci, A. and Palka, G. (1994) "Complex translocations of the Ph chromosome and Ph negative CML arise from similar mechanisms, as evidenced by FISH analysis", Cancer Genetics and Cytogenetics 78, 153-159.
18. Potter, A., Watmore, A., Cooke, P., Lilleyman, J. and Sokol, R. (1981) "Significance of non-standard Philadelphia chromosomes in chronic granulocytic leukemia", British Journal of Haematology 44, 51-54.
19. Bernstein, R., Pinto, M., Wallace, C., Penfold, G. and Mendelow, B. (1984) "The incidence, type and subsequent evolution of 14 variant Ph1 translocations in 180 South African patients with Ph1 chronic myeloid leukemia", Cancer Genetics and Cytogenetics 12, 225-228.
20. De Braekeleer, M. (1987) "Variant Philadelphia translocations in chronic myeloid leukemia", Cytogenetics and Cell Genetics 44, 215-222.
21. The Italian Cooperative Study Group on Chronic Myeloid Leukemia (1994) "Interferon-alpha 2b as compared with conventional chemotherapy for the treatment of chronic myeloid leukemia", New England Journal of Medicine 330, 820-825.
22. Druker, B.J., Tamura, S., Buchdunger, E., Ohno, S., Segal, G.M., Fanning, S., Zimmermann, J. and Lydon, N.B. (1996) "Effects of selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells", Nature Medicine 2, 561-566.
23. Druker, B.J., Talpaz, M., Resta, D.J., Peng, B., Buchdunger, E., Ford, J.M., Lydon, N.B., Kantarjian, H., Capdeville, R., Ohno-Jones, S. and Sawyers, C.L. (2001) "Efficacy and safety of a specific inhibitor of the bcr-abl tyrosine kinase in chronic myeloid leukemia", New England Journal of Medicine 344, 1031-1037.
24. Druker, B.J., Sawyers, C.L., Kantarjian, H., Resta, D.J., Reese, S.F., Ford, J.M., Capdeville, R. and Talpaz, M. (2001) "Activity of a specific inhibitor of the bcr-abl tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome", New England Journal of Medicine 344, 1038-1042.